ICH guideline Q8, Q9 and Q10 – questions and answers volume 4, 12/10 Anastasija Eschricht2022-12-07T10:18:27+00:00December 7th, 2022|
ICH Guideline Viral Safety evaluation Biotech products derived from cell lines of human or animal origin, Q5A(R2), 09/22 Anastasija Eschricht2022-12-07T10:16:18+00:00December 7th, 2022|
EMA Guideline Excipients in the dossier for application for marketing authorisation of a medicinal product, 06/07 Anastasija Eschricht2022-12-07T10:14:15+00:00December 7th, 2022|
EMA Guideline Plastic primary packaging materials, 05/05 Anastasija Eschricht2022-12-07T09:55:38+00:00December 7th, 2022|
FDA GFI, Statistical Approaches to Establishing Bioequivalence, DRAFT, 12/22 Anastasija Eschricht2022-12-06T13:31:20+00:00December 6th, 2022|
FDA GFI, Type V DMFs CDER-Led Combination Products Using Device Constituent Parts With Electronics or Software, DRAFT, 10/19 Beatrice Burtsov2022-12-06T12:59:42+00:00December 6th, 2022|